Trials / Recruiting
RecruitingNCT06512974
NeuroTrainer Cognitive Training For Academic Focus
A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 155 (estimated)
- Sponsor
- NeuroTrainer · Industry
- Sex
- All
- Age
- 11 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
Detailed description
The goal of this clinical trial is to test the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control function in students with and without attention-related difficulties. The main questions it aims to answer are (1) does NeuroTrainer improve attentional and executive control function, (2) does NeuroTrainer engage the target of ADHD inattention symptoms by identifying the target and demonstrating proximal changes in it, and (3) does NeuroTrainer demonstrate transfer of skill with improvement in academic behaviors. Researchers will compare students who use NeuroTrainer to a control condition to see if the NeuroTrainer intervention produces significant improvements. Participants in the intervention group will engage in virtual reality (VR) sessions which include physical activity and cognitive training. Cognitive training will maximize time at performance thresholds and optimize for variability in task dynamics and demands.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | NeuroTrainer | Virtual reality based cognitive training |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2026-02-28
- Completion
- 2026-02-28
- First posted
- 2024-07-22
- Last updated
- 2025-06-19
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06512974. Inclusion in this directory is not an endorsement.